Mosquito-Borne Infections Testing Global Market Report 2026

Mosquito-borne infections testing involves identifying viruses, parasites, or bacteria transmitted by mosquitoes that cause diseases in humans. It examines clinical samples such as blood or serum to confirm infections, detect the specific pathogen, and evaluate the severity of the disease, providing essential information for timely and effective treatment as well as for implementing targeted public health measures to control outbreaks.

The primary test types of mosquito-borne infections testing include molecular diagnostic tests, serological tests, rapid antigen tests, polymerase chain reaction (PCR) testing services, and laboratory reagent-based tests. Molecular diagnostic tests refer to advanced laboratory techniques utilized to detect genetic material of pathogens responsible for mosquito-borne diseases. The different sample types include blood samples, serum samples, plasma samples, urine samples, and saliva samples, and the various infection types involved are dengue, malaria, zika virus, chikungunya, west nile virus, and other infection types. The different technologies include enzyme-linked immunosorbent assay, lateral flow assay, polymerase chain reaction, next-generation sequencing, and other technologies, and they are utilized by several end users such as hospitals and clinics, diagnostic laboratories, public health agencies, research institutes, and point-of-care settings.

Tariffs are influencing the mosquito-borne infections testing market by increasing the cost of imported diagnostic kits, molecular testing reagents, and advanced laboratory instruments used for disease detection and surveillance. This is slowing the adoption of high-precision testing technologies, particularly in import-dependent regions such as Asia-Pacific and Latin America, where healthcare systems rely heavily on global suppliers. Molecular diagnostics and PCR-based testing segments are most affected because of their dependence on semiconductor-enabled equipment and specialized reagents. However, tariffs are also encouraging domestic manufacturing of diagnostic kits, strengthening regional supply chains, and driving investment in local healthcare diagnostics ecosystems, which may improve the long-term accessibility and resilience of testing infrastructure.

The mosquito-borne infections testing market research report is one of a series of new reports from The Business Research Company that provides mosquito-borne infections testing market statistics, including mosquito-borne infections testing industry global market size, regional shares, competitors with a mosquito-borne infections testing market share, detailed mosquito-borne infections testing market segments, market trends and opportunities, and any further data you may need to thrive in the mosquito-borne infections testing industry. This mosquito-borne infections testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mosquito-borne infections testing market size has grown strongly in recent years. It will grow from $1.44 billion in 2025 to $1.56 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to increasing prevalence of dengue and malaria outbreaks, limited access to advanced diagnostic infrastructure in developing regions, growing awareness of vector-borne disease burden, expansion of laboratory testing capacity in urban healthcare systems, rising government funding for infectious disease control programs.

The mosquito-borne infections testing market size is expected to see strong growth in the next few years. It will grow to $2.12 billion by 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to climate change driven expansion of mosquito habitats and disease transmission zones, increasing adoption of rapid molecular diagnostic technologies, growth in real time outbreak monitoring and predictive surveillance systems, rising demand for integrated public health data reporting systems, expansion of personalized and precision infectious disease diagnostics. Major trends in the forecast period include rising incidence of mosquito-borne outbreaks driving demand for rapid diagnostic testing, expansion of decentralized and point-of-care testing in rural and remote regions, increasing adoption of multiplex assays for simultaneous detection of multiple vector-borne pathogens, growing government-led surveillance and screening programs for early outbreak detection, rising preference for portable and field-deployable diagnostic kits for faster epidemic response.

The increasing incidence of dengue diseases is expected to propel the growth of the mosquito borne infections testing market going forward. Dengue is a mosquito-borne viral infection caused by the dengue virus and transmitted primarily by Aedes mosquitoes. The incidence of dengue diseases is rising due to warmer temperatures and increased rainfall, which create favorable breeding conditions for Aedes mosquitoes, along with rapid urbanization that increases human exposure to mosquito populations. Mosquito-borne infections testing contributes to early detection and monitoring of dengue infections by identifying the presence of the virus in patients, thereby enabling timely medical intervention and supporting public health measures to control the spread of the disease. For instance, in July 2023, according to the World Health Organization, a Switzerland-based intergovernmental organization, Brazil documented that of the 2,376,522 dengue cases recorded up to epidemiological week 26, 1,051,773 (44.2%) were laboratory-confirmed, and 1,249 (0.05%) were classified as severe dengue, reflecting a 13% increase compared to the same period in 2022. Therefore, the increasing incidence of dengue diseases is propelling the growth of the mosquito borne infections testing market.

The increasing international travel and trade is expected to propel the growth of the mosquito borne infections testing market going forward. International travel and trade refer to the movement of people and goods across countries for purposes such as tourism, business, and global commerce. International travel and trade are expanding due to the easing of COVID-19 restrictions, which has facilitated greater global mobility for travelers and strengthened the flow of goods across international borders. International travel and trade contribute to the movement of people and goods between regions, which can introduce mosquito-borne pathogens to new geographic areas, thereby necessitating enhanced monitoring and testing for these infections to prevent potential outbreaks. For instance, in May 2024, according to the National Travel and Tourism Office (NTTO), a US-based federal government agency, total international visitor arrivals of 66.5 million in 2023 increased by 15.7 million from 50.8 million in 2022, highlighting a significant rise in global travel. Therefore, the increasing international travel and trade is propelling the growth of the mosquito borne infections testing market.

Leading companies operating in the mosquito-borne infections testing market are focusing on developing innovative methods such as automated high-throughput immunoassays to deliver faster, more accurate, and scalable detection of mosquito-borne pathogens. Automated high-throughput immunoassays are laboratory tests that automatically detect specific antigens or antibodies in large numbers of samples, helping provide rapid, accurate, and scalable diagnosis of mosquito-borne infections compared to traditional manual tests. For example, in October 2025, F. Hoffmann-La Roche Ltd., a Switzerland-based biotechnology and diagnostics company, received CE mark for its Elecsys Dengue Ag test, an innovative automated immunoassay designed to detect the NS1 antigen of the dengue virus in human serum and plasma. This test operates on Roche's fully automated cobas e analysers, providing results in just 18 minutes and reliably detecting all four dengue virus serotypes. Key features include high clinical sensitivity and specificity, medium-to-high throughput of 120-300 tests per hour, enhanced traceability, and workflow efficiency, making it particularly useful during dengue outbreaks for rapid patient management and surveillance. The Elecsys Dengue Ag test represents a significant advancement over conventional methods, delivering consistent, fast, and comprehensive diagnostic capabilities across the entire patient journey.

Major companies operating in the mosquito-borne infections testing market are F. Hoffmann-La Roche Ltd, Trinity Biotech plc, Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings (LabCorp), Grifols S. A., Hologic Inc., bioMerieux SA, Bio-Rad Laboratories Inc., QIAGEN N. V., DiaSorin S. p. A., Euroimmun Medizinische Diagnostika AG, SD Biosensor Inc., Promega Corporation, Mayo Clinic Laboratories, Meridian Bioscience Inc., R-Biopharm AG, Boditech Med Inc., NanoEntek Inc., Entomogen Inc., J. Mitra and Co. Pvt. Ltd., Today's Clinical Lab Pvt. Ltd., Co-Dx Inc.

Asia-Pacific was the largest region in the mosquito-borne infections testing market in 2025. Latin America is expected to be the fastest-growing region in the forecast period. The regions covered in the mosquito-borne infections testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the mosquito-borne infections testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mosquito-borne infections testing market consists of revenues earned by entities by providing services such as vector surveillance and mosquito population monitoring, laboratory research and outbreak management, preventive screening, outbreak tracking and reporting, and public health consultation and planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The mosquito-borne infections testing market also includes sales of serological assay kits, rapid test kits, reagents and consumables, and laboratory equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mosquito-Borne Infections Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses mosquito-borne infections testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mosquito-borne infections testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mosquito-borne infections testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Test Type: Molecular Diagnostic Tests; Serological Tests; Rapid Antigen Tests; Polymerase Chain Reaction (PCR) Testing Services; Laboratory Reagent-Based Tests
• 2) By Sample Type: Blood Samples; Serum Samples; Plasma Samples; Urine Samples; Saliva Samples
• 3) By Infection Type: Dengue; Malaria; Zika Virus; Chikungunya; West Nile Virus; Other Infection Types
• 4) By Technology: Enzyme-Linked Immunosorbent Assay; Lateral Flow Assay; Polymerase Chain Reaction; Next-Generation Sequencing; Other Technologies
• 5) By End User: Hospitals And Clinics; Diagnostic Laboratories; Public Health Agencies; Research Institutes; Point-Of-Care Settings
• Subsegments:
• 1) By Molecular Diagnostic Tests: Nucleic Acid Amplification Testing; Reverse Transcription Polymerase Chain Reaction Testing; Multiplex Molecular Testing; Isothermal Amplification Testing; Pathogen Specific Genetic Testing
• 2) By Serological Tests: Immunoglobulin M Antibody Testing; Immunoglobulin G Antibody Testing; Antigen Detection Testing; Neutralization Assays; Enzyme Immunoassay Testing
• 3) By Rapid Antigen Tests: Point Of Care Antigen Testing; Lateral Flow Antigen Testing; Immunochromatographic Antigen Testing; Portable Rapid Diagnostic Testing; Field Based Antigen Testing
• 4) By Polymerase Chain Reaction Testing Services: Real Time Polymerase Chain Reaction Testing; Quantitative Polymerase Chain Reaction Testing; Multiplex Polymerase Chain Reaction Testing; Digital Polymerase Chain Reaction Testing; Reverse Transcription Polymerase Chain Reaction Testing
• 5) By Laboratory Reagent Based Tests: Reagent Kit Based Diagnostic Testing; Chemical Reaction Based Testing; Enzyme Reagent Testing; Staining Reagent Testing; Buffer Solution Based Testing
• Companies Mentioned: F. Hoffmann-La Roche Ltd; Trinity Biotech plc; Thermo Fisher Scientific Inc.; Abbott Laboratories; Laboratory Corporation of America Holdings (LabCorp); Grifols S.A.; Hologic Inc.; bioMerieux SA; Bio-Rad Laboratories Inc.; QIAGEN N.V.; DiaSorin S.p.A.; Euroimmun Medizinische Diagnostika AG; SD Biosensor Inc.; Promega Corporation; Mayo Clinic Laboratories; Meridian Bioscience Inc.; R-Biopharm AG; Boditech Med Inc.; NanoEntek Inc.; Entomogen Inc.; J. Mitra and Co. Pvt. Ltd.; Today's Clinical Lab Pvt. Ltd.; Co-Dx Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.